Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on April 21, 2025
Resmed Names Salli Schwartz as Chief Investor Relations Officer
GlobeNewswire
·
April 21, 2025
SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the appointment of Salli Schwartz as Chief Investor Relations …
Lipozem Reviews and Complaints: Is This Triple-BHB Fat Burner the Real Deal or Just Hype? – User Reviews Tested and Verified!
GlobeNewswire
·
April 21, 2025
Albany, New York, April 21, 2025 (GLOBE NEWSWIRE) -- Lipozem isn’t just another name in the weight loss world—it’s quickly becoming the buzzword for anyone tired of old-school diet struggles in 2025. Let’s face it: the “eat less, work out more” routine is …
Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development
GlobeNewswire
·
April 21, 2025
AUSTIN, Texas, April 21, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on developing novel, investigational treatments, including simufilam, for central nervous …
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
GlobeNewswire
·
April 21, 2025
GAITHERSBURG, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Galapagos Announces Executive Leadership Updates
GlobeNewswire
·
April 21, 2025
Mr. Henry Gosebruch appointed by the Galapagos Board of Directors as founding CEO of newly created SpinCo Dr. Paul Stoffels, Chair and CEO of Galapagos, plans to retire as CEO upon appointment of successor in the next 12 months and plans to continue as …
Best Cutting and Bulking Sarms 2025 - Fat Loss, Muscle Growth, Sarms Stack - Buy Sarms Online (Sarms For Sale) - Best Place to Buy Sarms - By CrazyBulk
GlobeNewswire
·
April 21, 2025
New York, April 21, 2025 (GLOBE NEWSWIRE) -- Considering cycles in the bodybuilding niche, the ultimate goal is to build lean muscle mass and eliminate excess fat. This is why, over time, SARMs have gained popularity; they can selectively target androgen …
Malignant Pleural Mesothelioma Market Poised for Growth Across the 7MM During the Study Period (2020–2034) Amid Advances in Immunotherapy and Targeted Drugs | DelveInsight
GlobeNewswire
·
April 21, 2025
New York, USA, April 21, 2025 (GLOBE NEWSWIRE) -- Malignant Pleural Mesothelioma Market Poised for Growth Across the 7MM During the Study Period (2020–2034) Amid Advances in Immunotherapy and Targeted Drugs | DelveInsight The malignant pleural …
LIPOZEM REVIEWS: How Reliable Is It? Investigation Completed 2025
GlobeNewswire
·
April 21, 2025
ST. PETERSBURG, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- Lipozem is an all-natural dietary supplement that uses only safe and natural components to promote healthy weight loss. With health and wellness taking center stage on a worldwide scale, there is a …
Hapbee Technologies Launching Highly Anticipated ‘Boosted Signals’ Feature with Upcoming New App Release
GlobeNewswire
·
April 21, 2025
VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCQB: HAPBF | FSE: HA1), a digital wellness technology company, today announced the upcoming rollout of a significant new feature—Boosted Signals—as …
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors
GlobeNewswire
·
April 21, 2025
MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive …
Reflect Scientific Inc. Announces Strategic Market Transition and Substantial Cost Savings
GlobeNewswire
·
April 21, 2025
OREM, Utah, April 21, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific Inc. (symbol: RSCF), a leading innovator in advanced refrigeration and cooling technologies, today announced significant financial improvements resulting from strategic market transitions …
Zevra Files Definitive Proxy Statement and Mails Letter to Stockholders
GlobeNewswire
·
April 21, 2025
Highlights 54.8% Total Stockholder Return Under Refreshed Board and Management Team Zevra Continues Growth Trajectory into a Global Commercial Rare Disease Company with Consistent Execution, New Product Launches, and Significant Financial Flexibility to …
BioCryst to Report First Quarter 2025 Financial Results on May 5
GlobeNewswire
·
April 21, 2025
RESEARCH TRIANGLE PARK, N.C., April 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2025 financial results on Monday, May 5, 2025. BioCryst management will host a …
Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines
GlobeNewswire
·
April 21, 2025
ROCKVILLE, Md. and SUZHOU, China, April 21, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs …
Apellis Announces Craig Wheeler to Join the Board of Directors
GlobeNewswire
·
April 21, 2025
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the Apellis Board of Directors, effective …
Alumis and ACELYRIN Announce Amended Merger Agreement
GlobeNewswire
·
April 21, 2025
ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis Merger …